Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C

Naoki Matsumoto; Akiko Ariga; Sakino To‐e; Hikaru Nakamura; Naoki Agata; Shin‐ichi Hirano; Jun‐ichiro Inoue; Kazuo Umezawa

doi:10.1016/s0960-894x(00)00114-1

Related publications

Article2000

ChemInform Abstract: Synthesis of NF‐ϰB Activation Inhibitors Derived from Epoxyquinomicin C.

Naoki Matsumoto, Akiko Ariga, Sakino To‐e, Hikaru Nakamura, Naoki Agata, Shin‐ichi Hirano, Jun‐ichiro Inoue, Kazuo Umezawa

Article2016

Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer

Allyson G. McLoed, Taylor P. Sherrill, Dong‐Sheng Cheng, Wei Han, Jamie A. Saxon, Linda A. Gleaves, Pingsheng Wu, Vasiliy V. Polosukhin, Michael Karin, Fiona E. Yull, Georgios T. Stathopoulos, Vassilis Georgoulias, Rinat Zaynagetdinov, Timothy S. Blackwell

Article2000

Vitamin C Inhibits NF-κB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase

Andrew Bowie, Luke O'neill

The Journal of Immunology

Letter2009

Activation of NF-κB transcription factor in asthma death

Gaetano Caramori, Tim Oates, Andrew G. Nicholson, Paolo Casolari, Kazuhiro Ito, Peter J Barnes, Alberto Papi, Ian M. Adcock, Kian Fan Chung

Article2001

Inhibition of JNK activation through NF-κB target genes

Guilin Tang, Yuzuru Minemoto, Benjamin Dibling, Nicole H. Purcell, Zhiwei Li, Michael Karin, Anning Lin